EMERYVILLE, Calif. (BUSINESS WIRE) Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, today announced the appointment of Thomas J. Dietz, Ph.D., to the company’s board of directors.Dr. Dietz brings to Nutcracker T.